AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -62.5% | 25,737 | -23.1% | 0.00% | – |
| Q1 2022 | $24,000 | -67.1% | 33,452 | +3.6% | 0.00% | – |
| Q4 2021 | $73,000 | +7.4% | 32,286 | +37.2% | 0.00% | – |
| Q3 2021 | $68,000 | +6.2% | 23,527 | +38.7% | 0.00% | – |
| Q2 2021 | $64,000 | +33.3% | 16,962 | +18.8% | 0.00% | – |
| Q1 2021 | $48,000 | +50.0% | 14,273 | +24.7% | 0.00% | – |
| Q4 2020 | $32,000 | -83.0% | 11,449 | -9.4% | 0.00% | -100.0% |
| Q4 2017 | $188,000 | +6166.7% | 12,641 | +4463.5% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 277 | +0.4% | 0.00% | – |
| Q4 2014 | $3,000 | – | 276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |